Home > Boards > Free Zone > Big Board Trading - Technical >

Biotech Ideas

RSS Feed
      Hide Sticky   Hide Intro
Moderator: gfp927z Assistants:
Search This Board: 
Last Post: 11/24/2020 10:25:28 PM - Followers: 3 - Board type: Free - Posts Today: 0

A board to discuss biotech ideas -


Aduro Biotech (ADRO) - Immunotherapy, cancer, autoimmune (213 - 33) (17 mil) -- (B) -- (255 mil) 
Cardiff Oncology (CRDF) - Cancer (36) --------------------------------------------------------- (B) -- (612 mil)
Chiasma (CHMA) - Acromegaly, transient permeability enhancer platform (92 - 2) ----- (B) -- (221 mil) 
ChemoCentryx (CCXI) - Inflammatory, autoimmune, cancer (72 - 21) (36 mil) -------- (B) -- (3.1 Bil)
Eagle Pharma (EGRX) - Critical care, oncolgy (109 - 42) (195 mil) ----------------------- (D-- (735 mil) 
Enanta (ENTA) - Infectious diseases, Hep C (373 - 10) (187 mil) -------------------------- (D) -- (1 Bil)
Kazia Therapeutics (KZIA) - Cancer (Australia) ------------------------------------------------ (B) -- (56 mil)
Kura Oncology (KURA) - Cancer (236 - 8) (n/a) ----------------------------------------------- (B) -- (639 mil)
Magenta Therapeutics (MGTA) - Autoimmune, MAB conjugates (145 - n/a) (n/a) ---- (B) -- (349 mil)
Macrogenics (MGNX) - Cancer, MABs, conjugates (215 - 30) (64 mil) ------------------- (B) -- (1.2 Bil)
MEI Pharma (MEIP) - Cancer (200 - 0) (4 mil) --------------------------------------------------- (B) -- (246 mil)
Minerva Neurosciences (NERV) - Neuro, psych (45 - 0) (n/a) ------------------------------ (B) -- (321 mil)
Otonomy (OTIC) - Neurotology (ears) (60 - 33) (1 mil) ---------------------------------------- (B) -- (62 mil)
Pieris Pharma (PIRS) - Asthma, respiratory, inflam, cancer, kidney (104 - 16) (46 mil) (B) - (148 mil)
Provention Bio (PRVB) - Immune-mediated diseases (76) (n/a) --------------------------- (B) -- (711 mil)
Synlogic (SYBX) - Metabolic, inflam, cancer (119 - 25) (2 mil) ------------------------------ (B) -- (75 mil)
Xenon Pharmaceuticals (XENE) - Neurological (141 - 16) (6 mil) ------------------------- (B) - (435 mil)


Acadia (ACAD) - Neurological, CNS (8 Bil) (697 - 10) (339 mil) -------------------------------------- (8 Bil)
Amgen (AMGN) - Blood cell stimulators, other ---------------------------------------------------------- (136 Bil)
Axsome Therapeutics (AXSM) - CNS disorders (220 - 20) (n/a) --------------------------------- (3.4 Bil)
Neurocrine Biosciences (NBIX) - Neurological, endocrine (670 - 503) (788 mil) --------------- (9 Bil)
Seattle Genetics (SGEN) - Cancer, autoimmune, armed MABs ----------------------------------- (24 Bil)


OTHER - 
***********
CytoDyn (CYDY) - Covid, HIV, Cancer (7 - 4) (n/a) --------------------------------------------------- (1.7 Bil)
Innovation Pharma (IPIX) - Cancer, inflam, antibiotics, acquired Polymedix, Cellceutix ---- (28 mil)



___________________________________________________________________
 

SPDR S&P Biotech ETF (XBI) (Exp - 0.35%, Assets - 3.5 Bil, Yld - 0.01%)

Name Symbol % Assets
Regeneron Pharmaceuticals Inc REGN 2.77%
Moderna Inc MRNA 2.65%
Gilead Sciences Inc GILD 2.43%
Vertex Pharmaceuticals Inc VRTX 2.32%
Biogen Inc BIIB 2.28%
United Therapeutics Corp UTHR 2.26%
Biomarin Pharmaceutical Inc BMRN 2.25%
Seattle Genetics Inc SGEN 2.16%
Exelixis Inc EXEL 2.06%
ACADIA Pharmaceuticals Inc ACAD 2.04%

__________________________________________________________________________

First Trust NYSE Arca Biotech Index (FBT) (Exp - 0.57%, Assets - 1.5 Bil, Yld - 0)

 

Name Symbol % Assets
Regeneron Pharmaceuticals Inc REGN 4.88%
Gilead Sciences Inc GILD 4.58%
Qiagen NV QGEN 4.48%
Biogen Inc BIIB 4.28%
Seattle Genetics Inc SGEN 4.08%
United Therapeutics Corp UTHR 3.93%
Vertex Pharmaceuticals Inc VRTX 3.89%
ACADIA Pharmaceuticals Inc ACAD 3.75%
Biomarin Pharmaceutical Inc BMRN 3.69%
Alnylam Pharmaceuticals Inc ALNY 3.53%

________________________________________________________________________
 

ARK Genomic Revolution ETF (ARKG) (Exp - 0.75%, Assets - 515 mil, Yld - 0)

Name Symbol % Assets
Invitae Corp NVTA 9.84%
CRISPR Therapeutics AG CRSP 9.34%
Illumina Inc ILMN 8.85%
Compugen Ltd CGEN 5.73%
Intellia Therapeutics Inc NTLA 5.62%
Iovance Biotherapeutics Inc IOVA 5.17%
Editas Medicine Inc EDIT 4.12%
Arcturus Therapeutics Holdings Inc ARCT 3.70%
Cellectis SA ADR CLLS.PA 3.47%
Guardant Health Inc GH 3.34%

_____________________________________________________________________________
 
PostSubject
#138   >>> Israeli scientist uses microbubbles to explode cancer cells gfp927z 11/24/20 10:25:28 PM
#137   >>> FDA allows emergency use of antibody drug gfp927z 11/22/20 11:55:12 AM
#136   >>> Kazia Presents Further Paxalisib Data At Sno, gfp927z 11/18/20 07:41:33 PM
#135   >>> Provention Bio, Inc. (PRVB), a clinical stage gfp927z 11/11/20 12:02:42 AM
#134   >>> Cardiff Oncology, Inc. (CRDF), a clinical-stage biotechnology gfp927z 11/10/20 10:11:07 PM
#133   >>> Highly effective vaccine, new warning signs, disrupted gfp927z 11/09/20 08:47:08 PM
#132   >>> Brainstorm Cell Therapeutics Inc. (BCLI), a biotechnology gfp927z 10/31/20 12:18:56 AM
#131   >>> Kamada Ltd. (KMDA) develops, produces, and markets gfp927z 10/31/20 12:15:41 AM
#130   >>> Greenlighting Gamida Cell (GMDA) - gfp927z 10/30/20 11:53:11 PM
#129   >>> Innovation Pharmaceuticals and George Mason University Announce gfp927z 10/30/20 11:32:09 PM
#128   >>> Regeneron to stop enrolling very sick COVID-19 gfp927z 10/30/20 03:32:33 PM
#127   >>> U.K. MHRA Clears CytoDyn to File its gfp927z 10/28/20 09:09:53 PM
#126   Humanigen - >>> National Institutes of Health Launches gfp927z 10/16/20 01:28:40 PM
#125   >>> CytoDyn: COVID-19 High Anxiety gfp927z 10/15/20 10:14:15 PM
#124   >>> “Serious adverse event” in AstraZeneca’s COVID-19 vaccine gfp927z 10/12/20 08:59:16 PM
#123   >>> The Top 5 COVID-19 Vaccine Candidates Explained gfp927z 10/10/20 03:09:52 PM
#122   Regeneron - >>> Antibody Drugs Touted by Trump gfp927z 10/09/20 07:34:37 PM
#121   >>> Humanigen's stock soars in active trading after gfp927z 10/06/20 09:05:30 PM
#120   >>> President Trump Received Regeneron Experimental Antibody Treatment gfp927z 10/02/20 06:23:04 PM
#119   >>> Timothy Ray Brown, First Patient to Be gfp927z 10/01/20 05:56:36 PM
#118   >>> Why Axsome Therapeutics Stock Is Sinking Today gfp927z 09/30/20 10:04:37 PM
#117   >>> Axsome Therapeutics Announces $225 Million Term Loan gfp927z 09/29/20 10:06:24 AM
#116   Is Lexaria Biotech ok to discuss? About Nasdaq; Alexulf 09/25/20 04:55:58 PM
#115   >>> Axsome Therapeutics Presents New Data from MOMENTUM gfp927z 09/24/20 11:41:40 AM
#114   >>> CytoDyn’s Phase 2 Study of Leronlimab for gfp927z 09/23/20 10:30:26 PM
#113   >>> Kazia Enters Clinical Collaboration With Dana-Farber Cancer gfp927z 09/22/20 09:57:01 PM
#112   >>> Axsome Therapeutics Announces Expedited Development of AXS-12 gfp927z 09/21/20 07:00:32 PM
#111   >>> Axsome Therapeutics Announces AXS-07 Phase 3 Migraine gfp927z 09/20/20 10:05:24 PM
#110   $LJPC rusty8350 09/16/20 03:34:57 PM
#109   Innovation Pharma - >>> Laboratory Testing of Brilacidin gfp927z 09/15/20 09:46:37 PM
#108   >>> Humanigen Announces Proposed Public Offering of Common gfp927z 09/15/20 09:39:12 PM
#107   >>> Humanigen and Lonza Announce Collaboration to Expand gfp927z 09/15/20 09:35:45 PM
#106   >>> Humanigen Announces Review of Lenzilumab Phase 3 gfp927z 09/14/20 07:29:20 PM
#105   >>> Axsome Therapeutics Presents New Data from GEMINI gfp927z 09/14/20 07:26:08 PM
#104   >>> Axsome Therapeutics to Present New Data for gfp927z 09/12/20 10:26:24 AM
#103   >>> Gamida Cell (GMDA) Presents Analysis of Observational gfp927z 09/10/20 11:46:18 AM
#102   Magenta Therapeutics - The bull case for MGTA gfp927z 09/04/20 02:12:15 PM
#101   Kazia Therapeutics - research report - gfp927z 09/04/20 02:07:34 PM
#100   Humanigen related - a re-post from another board - gfp927z 09/04/20 02:06:15 PM
#99   >>> U.K. MHRA Grants Meeting to CytoDyn to gfp927z 09/04/20 02:03:58 PM
#98   >>> We're Hopeful That Kazia Therapeutics (ASX:KZA) Will gfp927z 09/04/20 02:01:40 PM
#97   >>> Axsome Therapeutics Confirms Pivotal Status and Advancement gfp927z 09/04/20 01:57:49 PM
#96   Innovation Pharma - >>> Dr. William F. DeGrado, gfp927z 09/04/20 01:49:53 PM
#95   Humanigen - >>> Lenzilumab COVID-19 Case-Control Study Published gfp927z 09/02/20 09:57:31 AM
#94   >>> Axsome Therapeutics to Present Data from the gfp927z 08/30/20 12:11:25 PM
#93   >>> Kazia Therapeutics Limited (KZIA), an oncology-focused biotechnology gfp927z 08/27/20 06:29:54 PM
#92   CYDY - >>> The market for small biotechs gfp927z 08/27/20 05:40:20 PM
#91   >>> CytoDyn Reaches Enrollment of 195 Patients in gfp927z 08/27/20 01:26:53 PM
#90   >>> CytoDyn Will Attempt to Duplicate Berlin and gfp927z 08/25/20 11:14:55 AM
#89   >>> CytoDyn Submits its Top-line Report from its gfp927z 08/25/20 11:07:57 AM
PostSubject
Consent Preferences